Variable Responses to CFTR Correctors in vitro: Estimating the Design Effect in Precision Medicine by Elizabeth Matthes, Elizabeth Matthes, Julie Goepp, Julie Goepp, Carolina Martini, Carolina Martini, Jiajie Shan, Jiajie Shan, Jie Liao, Jie Liao, David Y. Thomas, David Y. Thomas, John W. Hanrahan, John W. Hanrahan, John W. Hanrahan

Connect to this object online.

Development of a novel antimicrobial peptide AWRK6 by Dusik  Kim, Zheng  Wang, Lili  Jin, Hanpin  Li, Junwei  Hwang, John  W. Hanrahan, Qiuyu Wang

Connect to this object online.

Decreasing Poly(ADP-ribose) Polymerase activity restores ΔF508 CFTR trafficking by Suzana Maria Anjos, Renaud eRobert, Daniel Dirck Waller, Donglei eZhang, Haouaria eBalghi, Heidi M. Sampson, Fabiana eCiciriello, Pierre eLesimple, Graeme eCarlile, Julie eGoepp, Jie eLiao, Pasquale eFerraro, Romeo ePhillipe, Francoise eDantzer, John W Hanrahan, David Y. Thomas

Connect to this object online.

Treatment With LAU-7b Complements CFTR Modulator Therapy by Improving Lung Physiology and Normalizing Lipid Imbalance Associated With CF Lung Disease by Amanda Centorame, Amanda Centorame, Daciana Catalina Dumut, Daciana Catalina Dumut, Mina Youssef, Martin Ondra, Martin Ondra, Irenej Kianicka, Juhi Shah, Radu Alexandru Paun, Radu Alexandru Paun, Tomas Ozdian, John W. Hanrahan, Ekaterina Gusev, Basil Petrof, Marian Hajduch, Marian Hajduch, Radu Pislariu, Juan Bautista De Sanctis, Juan Bautista De Sanctis, Danuta Radzioch, Danuta Radzioch, Danuta Radzioch, Danuta Radzioch

Connect to this object online.